Benefits

The mRNA Conference 2024 is the only event to deliver leading market intelligence and industry presentations on the latest technologies and techniques for discovering, developing, and manufacturing next-generation mRNA therapeutics, formulations, and clinical development.

 

Benefits of attending include:

• Two days of in-depth presentations revealing the latest market intelligence addressing the pharmaceutical industry’s collective focus by sharing results and industry experiences.
• Exclusive networking opportunity, a chance to engage with other professionals with shared challenges and experiences in this fast-developing sector.
• Updates on regional projects and research led by leading vaccination experts and manufacturers detailing their experiences, findings, and new proposals.
• Technical presentations from vaccine developers showcasing the latest results from recent tests and trials, technological developments, and new technical know-how.
• New case studies on specific examples from leading industry experts in global vaccine and treatment development initiatives.
• Unique opportunity to integrate with a multitude of manufacturers and seek new market opportunities by demonstrating an insight into this evolving industry.

 

Attending this conference will enable you to:

• Understand the current market dynamics of the biotech and pharmaceutical industry
• Learn how to develop strategies for vaccine design and development for viable cures
• Hear the latest trends with an overview of the year and projections for the biotech and pharmaceutical industries
• Discuss innovations and technological developments in vaccine delivery for better immune responses
• Access different ideas and perspectives from a multitude of experts and allied industries, combining regional experiences

 

Who should attend?

This event aims at leading biotech, pharmaceutical companies, government agencies, and policy think tanks seeking to learn more about innovations and technical know-how for drug discovery, development, and manufacturing. Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, Managers, and Stakeholders involved in:

 

mRNA Therapeutics	Vaccine Delivery Platforms	Clinical Trials and Approvals
Immunotherapeutics	Biological Engineering of Vaccines	Immunization Research & Development
Blockchain Technology	Structural Vaccinology Projects	Manufacturing Research & Innovation
mRNA Technologies	Advanced Live-Attenuated Vaccines	Research and Development
Genetic Engineering	Inactivated Vaccine Development	Strategy, Projects, & Public Affairs
DNA, mRNA Technologies	Cost Reduction Strategies	Legal and Compliance Work
Viral Vector-Based Vaccines	Sales and Marketing Initiatives	Equipment Certification Services
Nucleic Acid-Based Vaccines	Business Development	News Reporting and Journalism

 

From the following industries and companies:

Biotechnology Companies	Global Healthcare Institutions	Associations and Alliances
Pharmaceutical Companies	Clinical Research Organizations	Universities and Academia
Vaccination Developers	Vaccine Delivery Technologies	Research and Development
Vaccine Researchers	Vaccines Manufacturing	Government Agencies
Vaccine Technology Companies	Vaccinology Research & Development	Consultants and Advisors
Immunization Specialists	Biological Engineering Companies	Public Consultation Groups
Public Healthcare Providers	DNA and Messenger RNA Researchers	Legal and Compliance Services
Genetic Engineering Companies	International Quality Standards	News Reporters and Journalists

 

Book now
To secure your place at The mRNA Conference 2024 or if you require more information, please contact delegates@iQ-Hub.com.